Irish Stock Exchange listed pharmaceutical company Malin Corporation is looking to raise up to €31m through a placing of new shares.
The capital raised will be used to support the range of companies in which Malin itself has invested and, according to a statement issued by the company, "for general corporate purposes".
Malin has invested more than €365m in a range of pharmaeceutical ventures including antibiotics specialist Melinta and the medical learning softwre company 3D4Medical.
